Express Lane

Learning About Clinical Trials

Express Lane - Learning About Clinical Trials


Karen Anderson MD, Andrew Feigin MD, Samuel Frank MD

Learning About Clinical Trials

Answer our 2 question survey about this presentation.

What Do You Think?


Karen Anderson, MD

Karen Anderson, is a psychiatrist specializing in neuropsychiatry, and director of the Huntington’s Disease Care, Education and Research Center at MedStar Georgetown University Hospital. Dr. Anderson sees adult patients and families dealing with behavioral symptoms caused by neurological conditions such as Huntington’s disease, Parkinson’s disease, Alzheimer’s disease and brain injuries. She is also an associate professor of psychiatry and neurology at Georgetown University Medical Center. Dr. Anderson is currently the co-principal investigator on a clinical trial studying a medication to treat Huntington’s disease, and another studying a medication for tardive dyskinesia, a neurological disorder. Dr. Anderson is also involved in research to develop treatment for the behavioral symptoms of Parkinson’s disease, brain injury and Alzheimer’s disease. 

Andrew Feigin, MD

Andrew Feigin, a professor of Neurology at NYU Langone Health and co-director of the Marlene and Paolo Fresco Institute for Parkinson’s and Movement Disorders, has been involved in HD research since his participation in the Venezuela Collaborative Research Group, which isolated the HD gene 25 years ago. Dr. Feigin’s independent research has focused on the development of novel imaging biomarkers that could be used as outcome measures for HD clinical trials. He has served as chair of the Huntington Study Group, and currently serves as HSG’s Chief Medical Officer. Dr. Feigin is currently the North American Principal Investigator (PI) for the PROOF-HD study, was Principal Investigator of the SIGNAL trial, and has served as a site PI on numerous other HD trials. 

Samuel Frank, MD

Samuel Frank is a movement disorder neurologist at Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital for Harvard Medical School. After completing his residency and fellowship at the University of Rochester, he joined the neurology faculty at Boston University from 2004 to 2015. Dr. Frank was the principal investigator for First-HD and ARC-HD and a site investigator for many HD trials. He served as an investigator on the HSG executive committee. He was a member of the National HDSA Board of Trustee and locally serves as the director of the HDSA Center of Excellence at BIDMC. Dr. Frank is the inpatient neurology consultant for the specialized Huntington’s Disease service at Tewksbury State Hospital.